新冠疫苗的全球治理 - Suppr

Suppr

超能文献

Global governance for COVID-19 vaccines.

出版信息

Lancet. 2020 Jun 20;395(10241):1883. doi: 10.1016/S0140-6736(20)31405-7.

DOI:10.1016/S0140-6736(20)31405-7

PMID:32563355

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7302798/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8233/7302798/37002b3a2908/fx1_lrg.jpg

相似文献

Global governance for COVID-19 vaccines.

Lancet. 2020 Jun 20;395(10241):1883. doi: 10.1016/S0140-6736(20)31405-7.

COVID-19 vaccines for all?

Lancet. 2020 Jun 13;395(10240):1822-1823. doi: 10.1016/S0140-6736(20)31354-4.

[Not Available].

Rev Med Suisse. 2020 Jun 3;16(696):1176-1177.

COVID vaccination logistics: five steps to take now.

Nature. 2020 Nov;587(7833):194-196. doi: 10.1038/d41586-020-03134-2.

COVID-19 vaccines: no time for complacency.

Lancet. 2020 Nov 21;396(10263):1607. doi: 10.1016/S0140-6736(20)32472-7.

Why do SARS-COV vaccines not exist? The pharma scientific intelligence and business model must be revisited!

Expert Opin Drug Discov. 2020 Nov;15(11):1233-1235. doi: 10.1080/17460441.2020.1777980. Epub 2020 Jun 16.

Coronavirus vaccines get a biotech boost.

Nature. 2020 Jul;583(7817):647-649. doi: 10.1038/d41586-020-02154-2.

Covid-19 and the race for a vaccine.

Hist Cienc Saude Manguinhos. 2020 Jul-Sep;27(3):715-717. doi: 10.1590/S0104-59702020000400001.

If a coronavirus vaccine arrives, can the world make enough?

Nature. 2020 Apr;580(7805):578-580. doi: 10.1038/d41586-020-01063-8.

Keeping track of the SARS-CoV-2 vaccine pipeline.

Nat Rev Immunol. 2020 Nov;20(11):650. doi: 10.1038/s41577-020-00455-1.

引用本文的文献

Recipient-Reported Reactogenicity of Different SARS-CoV-2 Vaccination Regimens among Healthcare Professionals and Police Staff in Germany.

Vaccines (Basel). 2023 Jun 25;11(7):1147. doi: 10.3390/vaccines11071147.

Addressing Different Needs: The Challenges Faced by India as the Largest Vaccine Manufacturer While Conducting the World's Biggest COVID-19 Vaccination Campaign.

Epidemiologia (Basel). 2021 Sep 17;2(3):454-470. doi: 10.3390/epidemiologia2030032.

Attributes of national governance for an effective response to public health emergencies: Lessons from the response to the COVID-19 pandemic.

J Glob Health. 2022 Jul 6;12:05021. doi: 10.7189/jogh.12.05021.

Vaccine and inclusion.

J Public Econ Theory. 2022 Apr 27. doi: 10.1111/jpet.12590.

Attitudes Toward the Global Allocation of Chinese COVID-19 Vaccines: Cross-sectional Online Survey of Adults Living in China.

JMIR Public Health Surveill. 2022 Jun 7;8(6):e33484. doi: 10.2196/33484.

Common Demand vs. Limited Supply-How to Serve the Global Fight against COVID-19 through Proper Supply of COVID-19 Vaccines.

Int J Environ Res Public Health. 2022 Jan 25;19(3):1339. doi: 10.3390/ijerph19031339.

Global access to COVID-19 vaccines: a scoping review of factors that may influence equitable access for low and middle-income countries.

BMJ Open. 2021 Sep 30;11(9):e049505. doi: 10.1136/bmjopen-2021-049505.

Towards Solving Health Inequities: A Method to Identify Ideological Operation in Global Health Programs.

Int J Environ Res Public Health. 2021 Apr 21;18(9):4393. doi: 10.3390/ijerph18094393.

Next-Generation COVID-19 Vaccines Should Take Efficiency of Distribution into Consideration.

AAPS PharmSciTech. 2021 Apr 9;22(3):126. doi: 10.1208/s12249-021-01974-3.

International Collaboration to Ensure Equitable Access to Vaccines for COVID-19: The ACT-Accelerator and the COVAX Facility.

Milbank Q. 2021 Jun;99(2):426-449. doi: 10.1111/1468-0009.12503. Epub 2021 Mar 2.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验